Publications
2006
Bergemann R, Hauner H, Morris AD, Dinneen SF, Suissa SF, Gultyaev D, Maxion-Bergemann S, Müller E. Prediction of acute and chronic complications by a new computer simulation model for type 1 and type 2 diabetes: the Diabetes Mellitus Model (DMM). Journal of Medical Economics 2006; 9: 83-99.
Berman JM, Lumry WR, Stern LS, et al. Medication compliance and disease exacerbation in patients with asthma: A retrospective study of managed care data. Annals of Allergy, Asthma, and Immunology 2006(In press).
Bestehorn K, Hönig R, Clemens N, Kirch W. Register für klinische StudienŃeine kritische Bestandsaufnahme. Med Klin 2006 Feb 15;101(2):120-6.
Brennan A, Ara R, Sterz R, Matiba B, Bergemann R. Assessment of clinical and economic benefits of weight management with sibutramine in general practice in Germany. Eur J Health Econ. 2006 Dec;7(4):276-84.
Buchholz P, Steeds CS, Stern LS, et al. Utility assessment to measure the impact of dry eye disease. Ocular Surface 2006;4(3):155-61.
Bukstein DA, Murphy KR, Katz LM, McDermott L, Doyle JJ, Patel PA. Adherence with controller therapies and decreased asthma exacerbations in young children. In: Southwest Allergy Forum: Combined Meeting on Allergy, Asthma and Immunology; 2006 January Puerto Vallarta, Mexico; 2006.
Doyle JJ, Hershman DL, Neugut AI, Stern LS, Katz LM, Dolgitser M. Chemotherapy-related adverse events among breast cancer patients: A retrospective analysis of the SEER-Medicare database. In: American Society of Clinical Oncology; 2006 June Atlanta, Georgia; 2006.
Doyle JJ, Stern LS, Dolgitser M, Katz LM, Omar MA, Kahler KH. Treatment patterns and resource utilization in patients with PagetŐs disease treated with risedronate. In: ISPOR; 2006 May 20-24; Philadelphia, Pennsylvania; 2006.
Garver D, Lazarus A, Rajagopalan K, et al. Switching and concomitant prescriptions in bipolar patients: Relationship to race. Psychiatric Services 2006(In press).
Geary U, Lewis G, Erny S, Gyldmark M, Morlotti L, Walzer S. A sensitivity analysis of the cost per Quality Adjusted Life Year (QALY) of trastuzumab in the treatment of Early Breast Cancer (EBC). In: ISPOR 9th European Congress, Copenhagen, Danmark, October 28 - 31, 2006.
Katz LM, Howell J, Doyle JJ, et al. Outcomes and charges of elderly patients with acute myeloid leukemia. American Journal of Hematology 2006;81(11):850-7.
Lee P, Levin L, Walt J, et al. Characteristics Associated with Increased Healthcare Charges of Patients with Primary Open-Angle Glaucoma (POAG). In: American Academy of Ophthalmology; 2006 November 2006; Las Vegas, NV; 2006.
Lee PP, Walt JG, Doyle JJ, et al. A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma. Arch Ophthalmol 2006;124(1):12-9.
Lee PP, Walt JW, Doyle JJ, Stern LS, Katz LM, Siegartel LR. Association between IOP fluctuation and glaucoma progression. In: American Glaucoma Society; 2006 March Charleston, South Carolina; 2006.
Lewis G, Morlotti L, Creeden J, Gyldmark M, Peake MD. Cost-effectiveness of Erlotinib compared with Docetaxel for the treatment of relapsed Non-Small Cell Lung Cancer (NSCLC) in the UK . In: ISPOR 9th European Congress, Copenhagen, Danmark, October 28 - 31, 2006.
Lindgren P, Schwander B, Zöllner Y, Jönsson B. cost-utility analysis of Eprosartan compared to Enalapril and Ramipril in the treatment of moderate to severe hypertension in Sweden. In: ISPOR 9th European Congress, Copenhagen, Danmark, October 28 - 31, 2006.
Mannino DM, Shorr AF, Doyle JJ, et al. Prevalence of anemia in subjects with chronic obstructive pulmonary disease. In: American Thoracic Society; 2006 May; San Diego, California; 2006.
Marcus P, Oppenheimer EA, Patel PA, Katz LM, Doyle JJ. Use of nebulized inhaled corticosteroids among older adult patients: an assessment of outcomes. Annals of Allergy, Asthema, & Immunology 2006;96:736-43.
Maxion-Bergemann S, Thielecke F, Abel F, Bergemann R. Costs of irritable bowel syndrome in the UK and US. Pharmacoeconomics. 2006;24(1):21-37.
Maxion-Bergemann S, Walleser S, Müller E et al. Diabetes Mellitus Model (DMM): Internal Validation of a Computer-Simulation Model for Type 1 and Type 2 Diabetes. Journal of Medical Economics 2006; 9: 69-82.
Mills RP, Budenz DL, Lee PP, et al. Categorizing the stage of glaucoma from pre-diagnosis to end-stage disease. Am J Ophthalmol 2006;141(1):24-30.
Mueller E, Walzer S, Pieper L, Klotsche J, Stridde E. Comparing the development of a german diabetes population with respect to long-term outcomes using data from the DETECT Study and the EAGLE diabetes simulation model. In: ISPOR 9th European Congress, Copenhagen, Danmark, October 28 - 31, 2006.
Mueller E, Maxion-Bergemann S, Gultyaev D, Walzer S, Freemantle N, Mathieu C, Bolinder B, Gerber R, Kvasz M, Bergemann R. Development and validation of the Economic Assessment of Glycemic Control and Long-Term Effects of diabetes (EAGLE) model. Diabetes Technol Ther. 2006 Apr;8(2):219-36.
Mueller E, Rosery H, Walzer S, Bergemann R. Is the German Institute for Quality and Efficiency in Health Care (IQWiG) prepared for competitive decision making ? In: European Society for Medical Decision Making, 10th Biennial European Meeting, Birmingham, UK, June 11-13, 2006.
Mueller E., Walzer S, Huppertz E, Stridde E. Vergleich der deutschen und britischen Diabetes Leitlinien im Hinblick auf die Entwicklung von Spätkomplikationen: Simulationen mit dem EAGLE-Modell. [Comparison of the German and British diabetes guidelines in terms of late diabetic complications: Simulations with the EAGLE model.] In: German Diabetes Society, 41st Annual Meeting, Leipzig, Germany, May 24 - 27, 2006.
Murphy KR, Bukstein DA, Katz LM, McDermott L, Stern LS, Patel PA. Earlier use of nebulized inhaled corticosteroids is associated with fewer asthma exacerbations in young children. In: Southwest Allergy Forum: Combined Meeting on Allergy, Asthma and Immunology; 2006 January; Puerto Vallarta, Mexico; 2006.
Murphy KR, Bukstein DA, Katz LM, McDermott L, Stern LS, Patel PA. Earlier use of nebulized inhaled corticosteroids is associated with fewer asthma exacerbations in young children. In: The Western Society of Allergy, Asthma, and Immunology; 2006 January; Lanai, Hawaii; 2006.
Omar MA, Doyle JJ, Stern LS, Katz LM, Wang L, Kahler KH. Budget impact of introducing zoledronic acid to the formulary of a managed care organization for the treatment of PagetŐs disease of the bone. In: The Paget Foundation; 2006 January Fort Lauderdale, Florida; 2006.
Omar MA, Stern LS, Katz LM, Doyle JJ, Dolgitser M, Kahler KH. Extended use of bisphosphonates in PagetŐs disease patients. In: The Paget Foundation; 2006 January Fort Lauderdale, Florida; 2006.
Pasquale LR, Walt JG, Chiang TH, et al. Healthcare charges of patients with ocular hypertension. In: American Glaucoma Society; 2006 March Charleston, South Carolina; 2006.
Rosery H, Bergemann R, Marx SE, Boehnke A, Melnick J, Sterz R, Williams L. Health-economic comparison of paricalcitol, calcitriol and alfacalcidol for the treatment of secondary hyperparathyroidism during haemodialysis. Clin Drug Investig. 2006;26(11):629-38.
Rosery H, Bergemann R. Reimbursement of drugs in Germany - A Road Map for the Approval Process. In: ISPOR 9th European Congress, Podium Presentation, Copenhagen, Danmark, October 28 - 31, 2006.
Rosery H, Reimbursement of Ventricular Assist Devices in Europe - A Road Map for the Approval Process. In: 14th Congress of the ISRBP meeting, Leuven, Belgium, August 31 - September 2, 2006.
Shaheen NJ, Berenson KL, Doyle JJ, Brown KA. How Do Consumers Take "Over-the-Counter" Omeprazole? In: Digestive Disease Week; 2006 May 2006; Los Angeles, CA; 2006.
Shorr AF, Mannino DM, Doyle JJ, et al. The GOLD staging system: Implications for healthcare utilization. In: American Thoracic Society; 2006 May San Diego, California; 2006.
Shorr AF, Mannino DM, Doyle JJ, et al. Anemia in chronic obstructive pulmonary disease: Impact on resource utilization. In: American Thoracic Society; 2006 May San Diego, California; 2006.
Shorr AF, Stern LS, Raut MK, et al. Anemia and Transfusions Among Critically III Patients on Prolonged Mechanical Ventilation In: The American College of Chest Physicians Annual Meeting; 2006 October 21-26, 2006 Salt Lake City, UT 2006.
Shorr AF, Stern LS, Raut MK, et al. Anemia, Transfusions, and Outcomes Among Critically III Patients on Prolonged Mechanical Ventilation In: The American Society of Health System Pharmacists (ASHP) Midyear Clinical Meeting and Exhibition 2006, the 41st International Scientific Assembly of ASHP 2006 December 3-7, 2006 Anaheim, California 2006.
Stern L, Berman J, Lumry W, et al. Medication compliance and disease exacerbation in patients with asthma: a retrospective study of managed care data. Annals of Allergy, Asthma, & Immunology 2006;97:402-8.
Stern LS, Doyle JJ, Siegartel LR, Katz LM, Dolgitser M. Use of medication coverage methodology in measurement of patient compliance with pharmacotherapy. In: ISPOR; 2006 May Philadelphia, Pennsylvania; 2006.
Stern LS, Wiederkehr DW, Doyle JJ, Katz LM, Rajagopalan K. Association between atypical antipsychotic compliance and hopiltalization and emergency department visits in patients with bipolar disorder. In: The American Psychiatric AssociationŐs 159th Annual Meeting; 2006 May 20-25 Toronto, Ontario, Canada; 2006.
Traverso C, Walt J, Chiang T, et al. Effect of Intra-Ocular Pressure (IOP) Lowering Medication on Risk of Ocular Ischemic Events: A Case-Control Analysis. In: American Academy of Ophthalmology; 2006 November 2006; Las Vegas, NV; 2006.
Tomalik-Scharte D, Jetter A, Doroshyenko O, Achenbach H, Clemens N, Galliker S, Fuhr U. Comparison of pharmacokinetics of pyridostigmine in male and female subjects following single oral doses. In: 8th Annual Congress of Clinical Pharmacology, Würzburg, Germany, 2006 October 26-28. International Journal of Clinical Pharmacology and Therapeutics. 2006; 44(10), 526.
Tsai J, Walt JG, Doyle JJ, et al. Pharmacotherapy compliance and glaucoma surgery in patients with primary open-angle glaucoma. In: American Glaucoma Society; 2006 March Charleston, South Carolina; 2006.
Walt JG, Chiang T, Wang L, et al. The relationship of mean deviation scores and resource utilization among patients with glaucoma: A retrospective US chart review analysis. In: Association of Research Vision Ophthamology Annual Meeting (ARVO); 2006 April 30-May 4 Fort Lauderdale, Florida; 2006.
Walzer S , Huppertz E, Mueller E, Janka HU. Better HbA1c control with bot versus CT avouds long-term micro-vascular complications in patients with Tyoe-2-Diabetes: Model simulations with the DMM. In: ISPOR 9th European Congress, Copenhagen, Danmark, October 28 - 31, 2006.
Walzer S, Morlotti L, Mueller E. Comparison of two Budget Impact Modelling approaches: Impact of a new pharmaceutical product on annual health care expenditures and the impact on expenditures and insurance premiums. In: European Society for Medical Decision Making, 10th Biennial European Meeting, Birmingham, UK, June 11-13, 2006.
Walzer S, Memran M, Morlotti L. Modeling and Estimating Preferences Over Treatments for Breast Cancer: Applied conjoint analysis with physicians in Europe and United States. In: ISPOR 11th Annual International Meeting; Philadelphia, USA, May 20 - 24, 2006.
Walzer S, Bergemann R, Freemantle N, Mathieu C, Kvasz M, Marchant N, Mueller E. External Validation of the Economic Assessment of Glycemic Control and Long-term Effects of Diabetes (EAGLE) Model. In: 42nd EASD Meeting, Copenhagen-Malmoe, Sep 14-17, 2006.
Wentzloff J, Walt JG, Chiang TH, et al. Healthcare charges of patients with primary open-angle glaucoma. In: Association for Research in Vision and Ophthamology (ARVO); 2006 April 30-May 4; Fort Lauderdale, Florida; 2006.
Williams SA, Stern LS, McMurray JJ, et al. A pharmacoeconomic evaluation of the effects of candesartan on cardiovascular hospitalizations in patients with chronic heart failure. In: The 7th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke; 2006 May 7-9; Washington, DC; 2006.